• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CLSN:US

2.3500 USD 0.0700 2.89%

As of 16:30:00 ET on 12/22/2014.

Snapshot for Celsion Corp (CLSN)

Open: 2.4000 Day's Range: 2.3200 - 2.4200 Volume: 89,563
Previous Close: 2.4200 52wk Range: 2.3000 - 4.7400 1-Yr Rtn: -40.05%

Stock Chart for CLSN

No chart data available.
  • CLSN:US 2.3500
  • 1D
  • 1M
  • 1Y
2.4200
Interactive CLSN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLSN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3798
Est. EPS (USD) (12/2014) -1.4250
Est. PEG Ratio -
Market Cap (M USD) 47.94
Shares Outstanding (M) 19.98
30 Day Average Volume 72,317
Price/Book (mrq) 1.2063
Price/Sale (ttm) 85.0360
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLSN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CLSN

Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.

Michael H TardugnoChairman/President/CEOKhursheed AnwerExec VP/Chief Scientific Ofcr
Jeffrey W Church "Jeff"Senior VP/CFO/SecretaryNicholas BorysVP/Chief Medical Officer
More Company Profile & Key Executives for CLSN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil